167 related articles for article (PubMed ID: 27165105)
1. Determining breast cancer histological grade from RNA-sequencing data.
Wang M; Klevebring D; Lindberg J; Czene K; Grönberg H; Rantalainen M
Breast Cancer Res; 2016 May; 18(1):48. PubMed ID: 27165105
[TBL] [Abstract][Full Text] [Related]
2. A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients.
Li J; Jiang W; Liang Q; Liu G; Dai Y; Zheng H; Yang J; Cai H; Zheng G
BMC Genomics; 2020 Apr; 21(1):283. PubMed ID: 32252627
[TBL] [Abstract][Full Text] [Related]
3. Genome and transcriptome delineation of two major oncogenic pathways governing invasive ductal breast cancer development.
Aswad L; Yenamandra SP; Ow GS; Grinchuk O; Ivshina AV; Kuznetsov VA
Oncotarget; 2015 Nov; 6(34):36652-74. PubMed ID: 26474389
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.
Sotiriou C; Wirapati P; Loi S; Harris A; Fox S; Smeds J; Nordgren H; Farmer P; Praz V; Haibe-Kains B; Desmedt C; Larsimont D; Cardoso F; Peterse H; Nuyten D; Buyse M; Van de Vijver MJ; Bergh J; Piccart M; Delorenzi M
J Natl Cancer Inst; 2006 Feb; 98(4):262-72. PubMed ID: 16478745
[TBL] [Abstract][Full Text] [Related]
5. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
6. Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancer.
Pinto AE; Pereira T; Silva GL; André S
Breast; 2015 Aug; 24(4):449-55. PubMed ID: 25920680
[TBL] [Abstract][Full Text] [Related]
7. Identification of five hub genes as monitoring biomarkers for breast cancer metastasis in silico.
Cai Y; Mei J; Xiao Z; Xu B; Jiang X; Zhang Y; Zhu Y
Hereditas; 2019; 156():20. PubMed ID: 31285741
[TBL] [Abstract][Full Text] [Related]
8. A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients.
Sun J; Chen X; Wang Z; Guo M; Shi H; Wang X; Cheng L; Zhou M
Sci Rep; 2015 Nov; 5():16553. PubMed ID: 26549855
[TBL] [Abstract][Full Text] [Related]
9. Identifying potential prognostic biomarkers in head and neck cancer based on the analysis of microRNA expression profiles in TCGA database.
Wang X; Yin Z; Zhao Y; He M; Dong C; Zhong M
Mol Med Rep; 2020 Mar; 21(3):1647-1657. PubMed ID: 32016476
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of nuclear and histological grades as prognostic factors for invasive breast cancer.
Oshiro C; Yamasaki M; Noda Y; Nishimae A; Takahashi H; Inaji H
Breast Cancer; 2020 Sep; 27(5):947-953. PubMed ID: 32297249
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.
Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E
EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Novel RNA Sequencing-Based Prognostic Score for Acute Myeloid Leukemia.
Wang M; Lindberg J; Klevebring D; Nilsson C; Lehmann S; Grönberg H; Rantalainen M
J Natl Cancer Inst; 2018 Oct; 110(10):1094-1101. PubMed ID: 29506270
[TBL] [Abstract][Full Text] [Related]
13. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
14. Development of prognostic index based on autophagy-related genes analysis in breast cancer.
Lin QG; Liu W; Mo YZ; Han J; Guo ZX; Zheng W; Wang JW; Zou XB; Li AH; Han F
Aging (Albany NY); 2020 Jan; 12(2):1366-1376. PubMed ID: 31967976
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
16. Genomic grade adds prognostic value in invasive lobular carcinoma.
Metzger-Filho O; Michiels S; Bertucci F; Catteau A; Salgado R; Galant C; Fumagalli D; Singhal SK; Desmedt C; Ignatiadis M; Haussy S; Finetti P; Birnbaum D; Saini KS; Berlière M; Veys I; de Azambuja E; Bozovic I; Peyro-Saint-Paul H; Larsimont D; Piccart M; Sotiriou C
Ann Oncol; 2013 Feb; 24(2):377-384. PubMed ID: 23028037
[TBL] [Abstract][Full Text] [Related]
17. Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
Xiong J; Xiong K; Bing Z
Cancer Biomark; 2018 Feb; 21(3):535-546. PubMed ID: 29226853
[TBL] [Abstract][Full Text] [Related]
18. An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.
Chen J; Li Y; Han X; Pan Y; Qian X
Cancer Med; 2021 Mar; 10(5):1848-1859. PubMed ID: 33591634
[TBL] [Abstract][Full Text] [Related]
19. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Scoring System Based on 9 Glycolysis-Related Genes for Prognosis Prediction in Gastric Cancer.
Luo T; Du Y; Duan J; Liang C; Chen G; Jiang K; Chen Y; Chen Y
Technol Cancer Res Treat; 2020; 19():1533033820971670. PubMed ID: 33161837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
